ANI Pharmaceuticals: brands it owns and its ownership tree
ANI Pharmaceuticals (NASDAQ: ANIP) is a publicly listed company headquartered in Baudette, United States that owns 4 consumer brands and makes and sells 2 consumer brands under licence without owning the names.[1]
ANI Pharmaceuticals, Inc. is a Delaware corporation with its principal executive offices in Baudette, Minnesota. Its 10-K for 2025 calls it a diversified bio-pharmaceutical company that develops, manufactures and sells medicines through Rare Disease, Generics and Brands businesses, with a generics portfolio of more than 120 products and three owned manufacturing sites in Minnesota and New Jersey.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
divestitures recorded
Company facts
- Legal name
- ANI Pharmaceuticals, Inc.
- Type
- publicly listed company · see all publicly listed company owners
- Headquarters
- 🇺🇸 Baudette, United States
- Tickers
- NASDAQ: ANIP
- SEC CIK
- 0001023024
- Website
- www.anipharmaceuticals.com
- Last verified
- · 1 sources
ANI Pharmaceuticals in numbers
- ANI Pharmaceuticals owns 4 consumer brands tracked here across 1 top-level categories; the largest is healthcare & pharma with 4 brands.[1]
Everything ANI Pharmaceuticals owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree →
Brand portfolio by category
Minority stakes, joint ventures and licences
Recent changes to this record
ANI Pharmaceuticals in the global legal-entity registry
The Global Legal Entity Identifier Foundation (GLEIF) keeps an open register of legal entities. Each entity reports its own parents. We show it as a cross-check on the ownership recorded on this page, which is built from filings.
- Legal entity identifier (LEI)
- 5493000T6CXTND40YH31
- Registered name
- ANI PHARMACEUTICALS, INC. (US)
- Registration status
- Issued · record updated 27 May 2026
- Parent
- None named: its parent has not been disclosed publicly.
- Retrieved
- · GLEIF record (JSON)
Official recalls involving ANI Pharmaceuticals products
2 recall notices from government regulators matched to ANI Pharmaceuticals. Each applies to the specific products, sizes and lot codes named in the notice, not to every product sold under the name.
- hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC:… — FDA, · Class III
Reason given: Presence of foreign substance
Recalling firm: ANI Pharmaceuticals, Inc.
- Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20 — FDA, · Class II
Reason given: Defective Container; packets were found to be either empty or partially full.
Recalling firm: ANI Pharmaceuticals, Inc.
Matched automatically from FDA, USDA FSIS, UK Food Standards Agency and CPSC records only when the recalling firm corresponds to this ownership record and, for a brand, the brand name appears in the product description. Check the linked notice for exact products and lots. Method.
Frequently asked questions
What brands does ANI Pharmaceuticals own?
ANI Pharmaceuticals owns 4 consumer brands tracked here, including Purified Cortrophin Gel, ILUVIEN, YUTIQ and Inderal LA.
Is ANI Pharmaceuticals an American company?
Yes. ANI Pharmaceuticals is headquartered in Baudette, United States.
Who owns ANI Pharmaceuticals?
ANI Pharmaceuticals is a publicly listed company owned by its shareholders; it trades as ANIP on the NASDAQ.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] ANI Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27 — SEC EDGAR, SEC Form 10-K, published 27 February 2026; retrieved 18 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.